Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
BioOptics Stock Watch
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
IRIDEX Corporation - Common Stock
(NQ:
IRIX
)
0.9220
+0.0069 (+0.75%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 23, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about IRIDEX Corporation - Common Stock
< Previous
1
2
3
4
5
Next >
IRIX Stock Earnings: Iridex Misses EPS, Misses Revenue for Q1 2024
↗
May 14, 2024
IRIX stock results show that Iridex missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
May 14, 2024
Via
Benzinga
Iridex Reports First Quarter 2024 Financial Results
May 14, 2024
From
IRIDEX Corporation
Via
GlobeNewswire
Iridex to Report First Quarter 2024 Financial Results on May 14, 2024
May 08, 2024
From
IRIDEX Corporation
Via
GlobeNewswire
Iridex: Q4 Earnings Insights
↗
March 26, 2024
Via
Benzinga
Iridex's Earnings Outlook
↗
March 25, 2024
Via
Benzinga
Iridex: Q3 Earnings Insights
↗
November 14, 2023
Via
Benzinga
IRIDEX Corp. (NASDAQ: IRIX) Records 52-Week High Tuesday Morning
October 31, 2023
Via
Investor Brand Network
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
March 28, 2024
Via
Benzinga
IRIX Stock Earnings: Iridex Misses EPS, Misses Revenue for Q4 2023
↗
March 26, 2024
IRIX stock results show that Iridex missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
March 26, 2024
Via
Benzinga
Iridex Reports Fourth Quarter and Full Year 2023 Financial Results
March 26, 2024
Advances strategic review to unlock shareholder value
From
IRIDEX Corporation
Via
GlobeNewswire
Earnings Scheduled For March 26, 2024
↗
March 26, 2024
Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss at $0.66 per share on revenue of $16.68 million.
Via
Benzinga
Iridex Schedules Fourth Quarter and Full Year 2023 Financial Results and Update on Strategic Review Process for March 26, 2024
March 20, 2024
From
IRIDEX Corporation
Via
GlobeNewswire
Iridex Corporation Receives European Patent on MicroPulse Technology
February 06, 2024
The Advanced Short Pulse Laser System
From
IRIDEX Corporation
Via
GlobeNewswire
Iridex Announces First Patient Enrollment in MicroPulse® TLT Clinical Study Conducted in Collaboration with Imperial College Healthcare NHS Trust
January 24, 2024
From
IRIDEX Corporation
Via
GlobeNewswire
Iridex Launches New Iridex 532® and Iridex 577® Lasers in US Market Marking 35 Years of Laser Innovation in Treating Retina Disorders & Glaucoma
January 11, 2024
From
IRIDEX Corporation
Via
GlobeNewswire
Iridex Confirms Medicare Administrative Contractors Retired Local Coverage Determinations that Restricted Cyclophotocoagulation
December 28, 2023
Action Retains Full Patient Access to MicroPulse® Transscleral Laser Treatment
From
IRIDEX Corporation
Via
GlobeNewswire
Iridex Corporation Announces Successful Appeal for Revision of Recent Medicare LCDs to Provide Broader Coverage of Cyclophotocoagulation
November 27, 2023
From
IRIDEX Corporation
Via
GlobeNewswire
Iridex Reports Third Quarter 2023 Financial Results and Business Update
November 14, 2023
From
IRIDEX Corporation
Via
GlobeNewswire
Iridex to Host Third Quarter Financial Results Conference Call on November 14, 2023
November 13, 2023
The Company also announced plans to present at Stifel Healthcare Conference
From
IRIDEX Corporation
Via
GlobeNewswire
Dow Gains Over 100 Points; Fed Leaves Interest Rates Unchanged
↗
November 01, 2023
U.S. stocks traded higher toward the end of trading, after the Federal Reserve announced its policy decision. The Dow traded up 0.40% to 33,185.41 while the NASDAQ rose 0.92% to 12,969.54. The S&P 500...
Via
Benzinga
Topics
Economy
Stocks
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
November 01, 2023
Via
Benzinga
Nasdaq Surges Over 100 Points Ahead Of Fed Decision; WeWork Shares Plunge
↗
November 01, 2023
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 100 points on Wednesday. The Dow traded up 0.55% to 33,233.33 while the NASDAQ rose 0.87% to 12,962.92. The...
Via
Benzinga
Topics
Economy
Stocks
Why Extreme Networks Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
↗
November 01, 2023
Gainers
Via
Benzinga
US Stocks Mixed; Private Sector Payrolls Increase Less Than Expected
↗
November 01, 2023
U.S. stocks traded mixed this morning, ahead of interest rate decision from the Federal Reserve. Following the market opening Wednesday, the Dow traded down 0.05% to 33,036.63 while the NASDAQ rose...
Via
Benzinga
Topics
Economy
Stocks
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
November 01, 2023
Via
Benzinga
Iridex to Report Third Quarter Financial Results on November 14, 2023
October 26, 2023
From
IRIDEX Corporation
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
↗
September 04, 2023
Via
Benzinga
Why REX American Resources Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
↗
August 30, 2023
Gainers NanoVibronix, Inc. (NASDAQ: NAOV) shares jumped 89.5% to $2.7852 after the company reported outcomes from a UroShield study conducted at the University of Southampton in the U.K.
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
